Related Experiment Video
Updated: May 17, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Towards anatomical robust plan evaluation using a population-based model for head and neck cancer proton therapy
Nadine Vatterodt1,2, Albin Fredriksson3, Brian A Winey4
1Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
This study introduces anatomical robust plan evaluation (Ana-RE) using a population-based model to accurately predict anatomical variations in head and neck cancer proton therapy, outperforming traditional methods.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Biology
Background:
- Head and neck cancer proton therapy requires robust treatment planning to account for anatomical variations.
- Current robust plan evaluation methods primarily focus on setup uncertainties, potentially underestimating anatomical changes.
- Principal Component Analysis (PCA) offers a data-driven approach to model complex anatomical variations.
Purpose of the Study:
- To evaluate the efficacy of pre-treatment anatomical robust plan evaluation (Ana-RE) using a population-based PCA model.
- To determine if Ana-RE provides advantages over setup-based evaluation methods in head and neck cancer proton therapy.
- To assess the accuracy of Ana-RE in estimating the impact of inter-fractional anatomical variations.
Main Methods:
- A PCA model was developed using deformation vector fields from planning CT and weekly CBCTs of 20 oropharyngeal cancer patients.
- The PCA model was applied to five test patients to simulate anatomical scenarios.
- Proton therapy plans were evaluated using Ana-RE, conventional robust evaluation (Conv-RE), and probabilistic robust evaluation (Prob-RE), comparing their accuracy and ranking of plan robustness against daily dose variations (Daily-Ref).
Main Results:
- Ana-RE demonstrated superior agreement with reference daily dose variations (Daily-Ref), showing the lowest median absolute errors for clinical target volume (ΔV95% = 0.24%) and organs at risk (ΔDmax = 0.54 Gy, ΔDmean = 0.93 Gy).
- Ana-RE exhibited better identification of plan robustness differences, with a mean absolute rank difference of 2.3 compared to Conv-RE (2.7) and Prob-RE (2.9).
- Combining anatomical and setup uncertainties (Ana-RE-PS) further improved performance, achieving a mean absolute rank difference of 1.20.
Conclusions:
- Population-based anatomical robust plan evaluation (Ana-RE) accurately estimates the impact of inter-fractional anatomical variations in head and neck cancer proton therapy.
- Ana-RE offers significant advantages over conventional and probabilistic setup-based evaluation methods.
- Integrating anatomical and setup uncertainties enhances plan evaluation, supporting individualized treatment decisions.
More Related Videos
08:25Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022